Actively Recruiting

Phase Not Applicable
Age: 18Years +
All Genders
ID07426848

Occupational Therapy Symptom Management Through Innovative Lifestyle Engagement (OT SMILE): A Randomised Controlled Trial in Patients With Primary Brain Tumours

Led by Royal College of Surgeons, Ireland · Updated on 2026-02-23

96

Participants Needed

1

Research Sites

52 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

People diagnosed with primary brain tumours often face symptoms such as fatigue, cognitive changes, anxiety, and reduced ability to perform daily activities. These symptoms can result from the tumour or ongoing systemic anti-cancer treatments. Access to structured rehabilitation and symptom management programs is limited in Ireland. This trial evaluates whether a structured occupational therapy-led group program can improve quality of life and daily functioning in adults with primary brain tumours receiving active treatment. Participants will be randomly assigned to one of two groups: a six-week occupational therapy group program called OT SMILE or usual care which includes written lifestyle management information. The OT SMILE program consists of six weekly 90-minute group sessions led by occupational therapists, focusing on fatigue management, activity modification, cognitive strategies, relaxation techniques, goal setting, exercise, nutrition, and peer support. Participants in both groups will complete questionnaires before and after the six-week period to measure quality of life, fatigue, and daily functioning. The main goal is to determine if the occupational therapy program improves health-related quality of life compared to usual care. Assessments include the Functional Assessment of Cancer Therapy - Brain (FACT-BR), Brief Fatigue Inventory, and Canadian Occupational Performance Measure. The study is conducted at Beaumont Hospital and sponsored by the Royal College of Surgeons, Ireland.

CONDITIONS

Brief Title

OT SMILE: Occupational Therapy Group Intervention for Primary Brain Tumour Patients

Who Can Participate

Age: 18Years +
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Age 18 years or older
  • Diagnosis of primary brain tumour
  • Currently receiving systemic anti-cancer treatment
  • Experiencing difficulty with occupational performance (self-reported or clinician-identified)
  • Sufficient cognitive and communication ability to participate in group sessions
  • Eastern Cooperative Oncology Group (ECOG) performance status of 0, 1, or 2
  • Able to provide written informed consent
Not Eligible

You will not qualify if you...

  • Eastern Cooperative Oncology Group (ECOG) performance status of 3 or higher
  • Current inpatient status
  • Major depressive episode or significant psychiatric condition preventing participation in group sessions
  • Significant language barrier preventing participation in English-language sessions
  • Inability to provide informed consent

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Your Study Journey

Screening

Duration - 2 to 4 weeks

Participants are screened for eligibility to participate in the trial.

1 visit (in-person)

Outpatient Treatment

Duration - 6 weeks

Participants in the intervention group attend six weekly 90-minute occupational therapy group sessions focusing on symptom management, fatigue strategies, cognitive support, and peer support. Participants in the control group receive standard written lifestyle management information and continue usual oncology care without group sessions.

Weekly visits for 6 weeks

Follow-up

Duration - At completion of 6-week intervention

Outcome assessments are performed to evaluate changes in quality of life, fatigue, and occupational performance at the end of the intervention period.

1 visit (in-person)

Trial Site Locations

Total: 1 location

1

Beaumont RCSI Cancer Centre

Dublin, Beaumont, Ireland, D09V2N0

Actively Recruiting

Loading map...

Research Team

C

Caoilfhionn O Donovan

How is the study designed?

Study Type

INTERVENTIONAL

Masking

NONE

Allocation

RANDOMIZED

Model

PARALLEL

Primary Purpose

SUPPORTIVE_CARE

Number of Arms

2

Similar Trials

A Phase 1 Safety and Dose Finding Study of 131I-TLX101 Plus ...

Neoplastic Disease

Actively Recruiting

6 locations

A Phase 0/1 Study of BDTX-1535 in Recurrent High-Grade Gliom...

High Grade Glioma

Actively Recruiting

2 locations

An Open-Label Phase 1 Safety and Dose Finding Study of Orall...

Glioblastoma Multiforme of Brain

Actively Recruiting

3 locations

Frequently Asked Questions

Have more questions? Get in touch with our team for quick support

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here